The Crucial Importance of FDA’s Part 11 Compliance for Regulated Industries
Learn why FDA Part 11 compliance is essential for integrity in the pharmaceutical, biotechnology, and medical device industries. Discover the impacts of non-compliance and the importance of secure electronic records. Knowing how serious the Part 11 of Title 21 CFR regulations of the FDA are, is the best way to ensure integrity and trust in […]
Benefits and Challenges of Decentralized Clinical Trials: New FDA Guidance
Explore the advantages and challenges of decentralized clinical trials (DCTs) in light of the FDA’s new guidance. Learn about digital health technologies, patient engagement, and data management strategies. FDA Issues New Guidance for the Conduct of DCTs The Food and Drug Administration (FDA) has recently released new guidance on the conduct of decentralized clinical trials […]
A Comprehensive Guide to Successful Technology Transfer in the Pharmaceutical and Biotech Industry
Discover the essential aspects of technology transfer in the pharmaceutical and biotech industries, including risk management, regulatory compliance, and the benefits of collaborating with experts like BioBoston Consulting. Technology Transfer is an essential aspect for the pharmaceutical and biotechnology field as it allows effective transfer of knowledge, processes, and breakthroughs engineering from research and development […]
Safeguarding Drug Quality: Best Practices for Managing Returned Drug Products
Discover essential guidelines for managing returned drug products in the pharmaceutical industry, ensuring compliance, safety, and quality through effective procedures and regulations. Effective management of returned drug products is an essential part of pharmaceutical operations, necessitating complex activities to safeguard patients, as well as the pharmaceutical supply chain in general. To address these issues, regulatory […]
Streamlining CAR T Cell Manufacturing for Enhanced Therapeutic Outcomes
Explore the complexities of CAR T cell manufacturing, including regulatory guidance and personalized strategies to improve therapeutic outcomes in cancer immunotherapy. Recent years have seen the emergence of a promising newcomer to the cancer immunotherapy landscape – Chimeric Antigen Receptor (CAR) T-cell therapy. CHMP has paved the way for a unique treatment that uses a […]
Safeguarding Drug Integrity: Effective Management of Returned Drug Products
Learn about the complexities of returned drug product regulations and their critical importance for pharmaceutical manufacturers, distributors, and pharmacy staff in maintaining drug integrity and safety. Learn about the complexities of returned drug product law and why it is critical for pharmaceutical manufacturers, distributors and pharmacy staff. Returned Drug Product Regulation: Returned Drug Product Identification […]
Regulatory Considerations for mRNA Vaccine Variants: Ensuring Safety and Efficacy
Explore key regulatory considerations for mRNA vaccine variants, focusing on efficacy, safety, surveillance, and the role of consulting firms in navigating compliance challenges. Explore the fundamental regulatory considerations for mRNA vaccine variants, focusing on the key elements and approaches used by quality and regulatory consulting firms to guarantee compliance and performance in light of circulating […]
Quality System Record (QSR) in Medical Devices | FDA Compliance & Documentation
Learn the importance of the Quality System Record (QSR) in medical device manufacturing. Understand its role in FDA compliance, documentation, traceability, and quality control. Essential guide for manufacturers to maintain regulatory standards and improve product safety. The Quality System File is the foundation for compliance with the FDA Quality System Regulation (QSR), found in Part […]